Report Categories
View AllRecent Articles
View All
DJCO DailyJournal reports 254 percent Q4 2025 revenue growth shares add 278 percent in todays trading
Coinbase COIN Stock Strength or Weakness Analysis Coinbase posts 519 negative EPS miss trailing estimates
Beneficient BENF Stock Is It Forming a Reversal Weakens 20260420
How Metallus MTUS pricing changes flow through to earnings Q1 2026 EPS Beats Forecasts
WINA Winmark Corporation posts 92 percent Q1 2026 EPS miss shares dip 031 percent in todays trading
ALBT Avalon Globo climbs 336 percent following the release of its Q3 2023 earnings results
AIT Applied Ind shares drop 155 after Q1 2026 earnings narrowly miss consensus analyst EPS estimates
DJTWW TMTG Warr quarterly core financial metrics remain undisclosed as investors await official operational updates
VHCP Vine Hill outlines key longterm growth priorities in its latest quarterly earnings update
Reborn Coffee REBN Stock Today Drops 557 Key Support at 194 20260515
abrdn HQH Slides 133 as Selling Pressure Mounts 20260515
Calamos Conv CCD Stock Slides 174 Support at 2200 20260519
Lotus LOT Stock Slides 559 Support at 128 20260514
Nvidia Market Cap Surpasses Germanys GDP as Tech Giants Outweigh Major European Economies
Why USANA USNA Just Surged 372 Key Levels Ahead 20260520
TTEC Holdings TTEC Q1 2026 Miss Should Investors Be Worried
REGCO Q1 2026 Earnings Preferred Stock EPS Surpasses Estimates with 736 Beat
MTUS Q1 2026 Earnings EPS Beats Estimates by 1765 as Operational Efficiencies Drive Profitability
FHN Q1 2026 Earnings EPS Beats Estimates by 62 Stock Edges Lower on Caution
ELVA Q1 2026 Earnings EPS Surges Past Estimates with 307 Beat
CYN Q1 2026 Earnings EPS Beats Estimates Despite No Reported Revenue
Gold Resource Corporation GORO Q4 2025 Earnings Profitability Surprise Amid Modest Operations
Jade Biosciences Inc JBIO Holds Steady as Price Consolidates Near Key Resistance
Lifetime Brands LCUT Faces Modest Pressure Testing Key Support Levels
Equity Residential EQR Posts Modest Gains Key Support and Resistance Levels in Focus
TG Therapeutics TGTX Slips Modestly as Stock Consolidates Near Key Support Levels